PharmaShots | Incisive News in 3 Shots

Subscribe Now

IPR Rights

Aclaris to Divest its Rhofade (oxymetazoline hydrochloride) with all IPR Rights to EPI Health

Aclaris to Divest its Rhofade (oxymetazoline hydrochloride) with all IPR Rights to EPI Health

October 11, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us